NVOX was created on 2024-12-03 by Defiance. The fund's investment portfolio concentrates primarily on health care equity. NVOX seeks to deliver 2x leveraged exposure to the daily share price movement of NOVO Nordisk A/S - ADR (NVO), less fees and expenses, through derivatives like swap agreements.